Council Members in this Study Group: 57
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Leading institutions connect with members of this Study Group through GLG
John WaughDirector of System Laboratory Operations
HENRY FORD HEALTH SYSTEM ![]()
John Waugh is the Director of System Laboratory Operations at Henry Ford Health System, one of the top ten US laboratories in size. In this research and academic medical center in Detroit, Mr. Waugh has expertise in new and emerging clinical and molecular diagnostic systems, including products andservices...
Stan Schofield, MS, MHA,MT(ASCP)Managing Principal
The Compass Group, Scarborough ![]()
Stan Schofield, MS, MHA, MT (ASCP), is President of NorDx, a regional laboratory corporation which is part of the Maine Health System. He also serves as a Vice President and senior member of the health system executive management team. Mr. Schofield is the Managing Principal of the Compass Group, a...
Associate Professor, Pathology
NEW YORK UNIVERSITY (INC) ![]()
Robert Boorstein, MD, PhD, is an Associate Professor in the Department of Pathology at New York University School of Medicine, where he directs clinical pathology training. Previously, Dr. Boorstein was the Director of Pathology at Bellevue Hospital and the Medical Director for Pathology and Laboratory...
Ken PowellPresident
Genesis Business Development, LLC ![]()
Ken Powell is the President of Genesis Business Development, a healthcare consultancy. Mr. Powell has experience in the identification, acquisition, and commercialization of intellectual property, new businesses, and products in the clinical diagnostics and medical device market segments. He has knowledge...
Chief Administrative Officer
KAISER FOUNDATION HOSPITALS INC ![]()
Carrie Harris-Muller is the Chief Administrative Officer of Kaiser Permanente in the Mid-Atlantic States. Previously, Ms. Harris-Muller served as the Regional Vice President of HealthPlan Administration and Contracting. She has held several executive leadership positions in healthcare, including Cigna...
Founder and Senior Pathologist
Chestatee Pathology Associates, PC ![]()
John Cochran, MD, is the Founder and the Chief Executive Officer of Chestatee Pathology Associates in Atlanta, GA. He is also the Medical Director of two Atlanta-area hospital laboratories and founded the first independent podiatric pathology laboratory in the U.S. Dr. Cochran has consulted on thefollowing...
Medical Director
PROVIDENCE HEALTH CARE ![]()
Joseph Schappert, MD, is the Chief Medical Officer at Pathology Associates Medical Laboratories (PAML) and the Medical Director for Providence Health Care System. He was previously the Global Medical Director at ICON Central Laboratories, where he was involved in innovative and state-of-art information...
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Will Quest Acquire Vermillion?
November 20, 2009
Ken Powell, President, Genesis Business Development, LLC
Why Quest Will Acquire Vermillion | www.genomeweb.com
Quest Diagnostics has had a known relationship with Vermillion. Now that Vermillion has received FDA approval for its OVA1 in vitro diagnostic multi-variant index assay (IVDMIA) and Quest has an exclusive three year marketing license and a 17% investment in the company plus additional loans, acquisition...
Roche Receives H1N1 FDA Emergency Use Authorization
November 16, 2009
Ken Powell, President, Genesis Business Development, LLC
Roche Gets FDA EUA for H1N1 Test Kit | www.genomeweb.com
Roche has received an Emergency Use Authorization from the FDA for its RealTime ready Influenza A/H1N1 Detection Set. The new H1N1 assay is run on its MagNA Pure LC platform for nucleic acid isolation and its LightCycler 2.0 system for real-time PCR applications. Roche, the worldwide clinical diagnostics...
November 14, 2009
Ken Powell, President, Genesis Business Development, LLC
Sequenom Shareholders Sue Company, Officials over SEQureDx Data Mishandling | www.genomeweb.com
The Sequenom sage appears endless. Following the "mishandling of data" involving the company's Down's syndrome test, termination of company executives, investigation by the NASDAQ , the SEC and the US Attorney for the Southern District of California, Xenomics lawsuit against Sequenom seeking up...
Epigenomics Reports Excellent 3Q Returns
November 12, 2009
Ken Powell, President, Genesis Business Development, LLC
Epigenomics Nearly Quadruples Sales in Q3 | www.genomeweb.com
Germany based Epigenomics posted stellar Q3 financial results and reduced net loss by 8%. According to the company, the increase comes from existing collaborations, new partnerships, and license agreements
November 12, 2009
Ken Powell, President, Genesis Business Development, LLC
Life Technologies to Buy Biotrove, Which Will Form Mass Spec Sample Prep Company | www.biotrove.com
Following on Life Technologies' (NASDAQ: LIFE) acquisition of Biotrove, Biotrove announced in a separate release that it will form a subsidiary for a sample handing company for mass spectroscopy systems. This could be the real opportunity for future growth.
Leading Experts in Pricing Experts on Clinical Lab Testing in the U.S. Study Group have not participated in any upcoming seminars.
View All GLG Live Meetings in Healthcare
Leading Experts in Pricing Experts on Clinical Lab Testing in the U.S. have not participated in any GLG webcasts.